Compare NWTG & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWTG | NDRA |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 7.3M |
| IPO Year | N/A | 2017 |
| Metric | NWTG | NDRA |
|---|---|---|
| Price | $1.85 | $5.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | ★ 173.3K | 83.1K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,931,000.00 | N/A |
| Revenue This Year | $120.41 | N/A |
| Revenue Next Year | $70.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 178.24 | N/A |
| 52 Week Low | $0.82 | $2.90 |
| 52 Week High | $49.80 | $11.96 |
| Indicator | NWTG | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 67.16 | 47.69 |
| Support Level | $1.49 | $4.14 |
| Resistance Level | $1.75 | $6.24 |
| Average True Range (ATR) | 0.18 | 0.82 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 91.02 | 48.40 |
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.